MMedication Read More Vanda Jumps 21% After FDA Approves Motion Sickness Therapy31 December 2025 This article first appeared on GuruFocus. Vanda Pharmaceuticals (NASDAQ:VNDA) jumped roughly 21% in premarket trading after the U.S.…